The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•16 April 2026•

1 min read

Mixed Analyst Price Target Revisions for Industrial and Healthcare Firms

Key Facts

1RBC Capital Markets raised Eaton Corporation's (ETN) price target to $457 from $439, maintaining an 'Outperform' rating.

2Truist cut Medtronic's (MDT) price target to $95 from $103, maintaining a 'Hold' rating.

3RBC made minor adjustments to price targets for W.W. Grainger (trimmed to $1,170) and Veralto (raised to $99).

Version History

1 additional source confirmed this story

Analysts from RBC Capital Markets and Truist have issued several price target revisions for major industrial and medical technology firms, reflecting a divergence in market sentiment. RBC Capital Markets raised Eaton Corporation's (ETN) price target to $457 from $439, maintaining an 'Outperform' rating based on strong sector performance. Conversely, Truist cut Medtronic's (MDT) price target to $95 from $103 while keeping a 'Hold' rating, signaling a more cautious outlook for the healthcare equipment provider. Additional minor adjustments by RBC included trimming W.W. Grainger's target to $1,170 and raising Veralto's to $99. These revisions follow the recent Q1 earnings season and reflect updated analyst outlooks based on individual company guidance. Overall, the updates present a mixed landscape, balancing bullish industrial sentiment against bearish adjustments in healthcare.